ArticleCureus2026
A Case of a 31-Year-Old Female Patient With Systemic Lupus Erythematosus Presenting With Lupus-Associated Pleural Effusions and Newly Diagnosed Lupus Nephritis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multiorgan involvement and the presence of antinuclear antibodies (ANA). Given the potential for multiorgan involvement, patients with SLE can present with a variety of phenotypes. The most common presenting symptoms of SLE are constitutional, such as fevers, fatigue, malaise, and weight loss. This is followed in prevalence by cutaneous and musculoskeletal manifestations. Pulmonary, renal, and gastrointestinal manifestations occur at similar rates of prevalence. Workup of SLE involves checking autoantibodies and complement levels. Management of SLE is highly complex and varies based on disease severity as well as clinical presentation. Current guidelines recommend the use of hydroxychloroquine in all patients with SLE (unless contraindicated) along with other immunomodulators. In this article, we present the case of a 31-year-old woman with previously diagnosed SLE who presented with both pulmonary and renal manifestations. We discuss the disease progression, as well as an overview of the management for these manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.